19 insiders reported 71 Form 4 transactions for Longeveron Inc. (LGVN) over the past 18 months (most recent 2026-08-25). Recent activity: Jhaveri Nirav S. (Chief Financial Officer) Buy 300,000 shares, Hare Joshua (Chief Scientific Officer) Buy 286,000 shares, Cann Leah Rush (Director) Buy 36,000 shares, Ascheim Deborah (Director) Buy 36,000 shares, Soffer Rock (Director) Buy 36,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Jhaveri Nirav S. | Chief Financial Officer | Buy | 300,000 | $0 |
| 2026-08-21 | Hare Joshua | Chief Scientific Officer | Buy | 286,000 | $0 |
| 2026-08-21 | Cann Leah Rush | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Ascheim Deborah | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Soffer Rock | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Lehr Paul T | General Counsel, Secretary | Buy | 286,000 | $0 |
| 2026-08-21 | Ungaro Ursula | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Desai Arjun JJ | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Agafonova Nataliya | Chief Medical Officer | Buy | 286,000 | $0 |
| 2026-08-21 | Hajjar Roger Joseph | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Blass Devin | CTO & SVP of CMC | Buy | 286,000 | $0 |
| 2026-08-21 | Paletta George A. Jr. | Director | Buy | 36,000 | $0 |
| 2026-07-08 | Hare Joshua | Chief Scientific Officer | Buy | 600,000 | $0 |
| 2026-07-06 | Willard Stephen H | Chief Executive Officer | Sell | 18,046 | $13,157 |
| 2026-07-06 | Lehr Paul T | General Counsel, Secretary | Sell | 13,143 | $9,583 |
| 2026-07-06 | Agafonova Nataliya | Chief Medical Officer | Sell | 22,505 | $16,408 |
| 2026-07-06 | Locklear Lisa | Chief Financial Officer | Sell | 22,505 | $16,408 |
| 2026-07-06 | Blass Devin | CTO & SVP of CMC | Sell | 15,808 | $11,526 |
| 2026-05-05 | Locklear Lisa | Chief Financial Officer | Buy | 250,000 | $0 |
| 2026-05-05 | Lehr Paul T | General Counsel, Secretary | Buy | 250,000 | $0 |
| 2026-05-05 | Willard Stephen H | Chief Executive Officer | Buy | 500,000 | $0 |
| 2026-05-05 | Blass Devin | CTO & SVP of CMC | Buy | 250,000 | $0 |
| 2026-05-05 | Agafonova Nataliya | Chief Medical Officer | Buy | 250,000 | $0 |
| 2026-04-03 | Agafonova Nataliya | Chief Medical Officer | Sell | 13,145 | $14,722 |
| 2026-04-03 | Lehr Paul T | General Counsel, Secretary | Sell | 5,611 | $6,284 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25